Company / Cost of Revenue
PAVmed Inc. Cost of Revenue History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$4.8M
FY2025
5-year range
$585.0K / $6.4M
FY2021-FY2025
Trend
-24.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $4M to $5M over the past 2 years.
Based on SEC 10-K filings.
$5M in FY2025 with a 3-year CAGR of +102.3%.
Increased from $4M to $5M over the past 2 years.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +102.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +102.3%, indicating consistent growth.
- In FY2025, cost of revenue decreased 24.6% year-over-year.
- Peak cost of revenue was recorded in FY2024.
- Lowest cost of revenue in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -0.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.8M | -24.6% |
| FY2024 | $6.4M | +77.6% |
| FY2023 | $3.6M | +517.8% |
| FY2022 | $585.0K | +0.0% |
| FY2021 | $585.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026